Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gesine Bug

Showing results (41-50 of 165) with videos related to

Pageof 17
Sort By:
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cellsAnnette Romanski, Kerstin Schwarz, Maren Keller, et al.
Molecular Oncology|August 30, 2014
Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1Monika Raab, Andrea Krämer, Stephanie Hehlgans, et al.
Journal of Translational Medicine|August 13, 2017
Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMCSoo-Zin Kim-Wanner, Gesine Bug, Juliane Steinmann, et al.
Bone Marrow Transplantation|April 21, 2022
Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19Christian Niederwieser, Bodo Weber, Mirjam Reichard, et al.
Cytotherapy|October 7, 2011
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cellsEva Rettinger, Selim Kuçi, Ivonne Naumann, et al.
Vox Sanguinis|April 29, 2020
Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcomeOlivier Ballo, Philine Fleckenstein, Fagr Eladly, et al.
BMC Pharmacology & Toxicology|September 30, 2020
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemiaFabian Lang, Lydia Wunderle, Susanne Badura, et al.
Annals of Hematology|November 26, 2024
Central nervous system relapse after allogeneic HCT in FLT3-mutated AMLKhouloud Kouidri, Fabian Acker, Rosa Toenges, et al.
Journal of Immunological Methods|August 16, 2011
Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapseMelanie Bremm, Sabine Huenecke, Thomas Lehrnbecher, et al.
Cancer|November 19, 2005
Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemiaGesine Bug, Markus Ritter, Barbara Wassmann, et al.
Pageof 17

Showing results (41-50 of 165) with videos related to

Sort By:
Pageof 17
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cellsAnnette Romanski, Kerstin Schwarz, Maren Keller, et al.
Molecular Oncology|August 30, 2014
Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1Monika Raab, Andrea Krämer, Stephanie Hehlgans, et al.
Journal of Translational Medicine|August 13, 2017
Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMCSoo-Zin Kim-Wanner, Gesine Bug, Juliane Steinmann, et al.
Bone Marrow Transplantation|April 21, 2022
Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19Christian Niederwieser, Bodo Weber, Mirjam Reichard, et al.
Cytotherapy|October 7, 2011
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cellsEva Rettinger, Selim Kuçi, Ivonne Naumann, et al.
Vox Sanguinis|April 29, 2020
Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcomeOlivier Ballo, Philine Fleckenstein, Fagr Eladly, et al.
BMC Pharmacology & Toxicology|September 30, 2020
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemiaFabian Lang, Lydia Wunderle, Susanne Badura, et al.
Annals of Hematology|November 26, 2024
Central nervous system relapse after allogeneic HCT in FLT3-mutated AMLKhouloud Kouidri, Fabian Acker, Rosa Toenges, et al.
Journal of Immunological Methods|August 16, 2011
Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapseMelanie Bremm, Sabine Huenecke, Thomas Lehrnbecher, et al.
Cancer|November 19, 2005
Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemiaGesine Bug, Markus Ritter, Barbara Wassmann, et al.
Pageof 17